These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18380629)

  • 1. Cost-effectiveness and value of information analyses of neuraminidase inhibitors for the treatment of influenza.
    Wailoo AJ; Sutton AJ; Cooper NJ; Turner DA; Abrams KR; Brennan A; Nicholson KG
    Value Health; 2008; 11(2):160-71. PubMed ID: 18380629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of newer treatment strategies for influenza.
    Smith KJ; Roberts MS
    Am J Med; 2002 Sep; 113(4):300-7. PubMed ID: 12361816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review and economic decision modelling for the prevention and treatment of influenza A and B.
    Turner D; Wailoo A; Nicholson K; Cooper N; Sutton A; Abrams K
    Health Technol Assess; 2003; 7(35):iii-iv, xi-xiii, 1-170. PubMed ID: 14609480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy.
    Rothberg MB; Bellantonio S; Rose DN
    Ann Intern Med; 2003 Sep; 139(5 Pt 1):321-9. PubMed ID: 12965940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation.
    Tappenden P; Jackson R; Cooper K; Rees A; Simpson E; Read R; Nicholson K
    Health Technol Assess; 2009 Feb; 13(11):iii, ix-xii, 1-246. PubMed ID: 19215705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
    Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
    Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oseltamivir for treatment of influenza in healthy adults: pooled trial evidence and cost-effectiveness model for Canada.
    O'Brien BJ; Goeree R; Blackhouse G; Smieja M; Loeb M
    Value Health; 2003; 6(2):116-25. PubMed ID: 12641862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of influenza symptoms in healthy adults.
    Rothberg MB; He S; Rose DN
    J Gen Intern Med; 2003 Oct; 18(10):808-15. PubMed ID: 14521643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoeconomic assessment of oseltamivir in treating influenza--the case of otherwise healthy Danish adolescents and adults.
    Vindt Holm M; Gyldmark M; Holme Hansen E
    Pharm World Sci; 2004 Dec; 26(6):339-45. PubMed ID: 15683104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral agents for influenza: a comparison of cost-effectiveness data.
    Lynd LD; Goeree R; O'Brien BJ
    Pharmacoeconomics; 2005; 23(11):1083-106. PubMed ID: 16277546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.
    Garside R; Pitt M; Somerville M; Stein K; Price A; Gilbert N
    Health Technol Assess; 2006 Mar; 10(8):1-142, iii-iv. PubMed ID: 16545207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacoeconomic study of anti-influenza virus drugs in Japan based on a network meta-analysis.
    Nakagawa N; Kanazawa Y; Morikawa A; Lai L
    J Antimicrob Chemother; 2024 Jul; 79(7):1590-1596. PubMed ID: 38775746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Cost-Effectiveness Analysis of Neuraminidase Inhibitors for Influenza Virus Infections in an Adult-Outpatient Setting in Japan.
    Nakagawa N; Morikawa A; Kanazawa Y; Lai L
    Value Health Reg Issues; 2021 May; 24():117-122. PubMed ID: 33556804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of surgical insertion of ventilation tubes for the management of persistent bilateral otitis media with effusion in children.
    Mohiuddin S; Schilder A; Bruce I
    BMC Health Serv Res; 2014 Jun; 14():253. PubMed ID: 24927784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of oseltamivir for influenza treatment considering the virus emerging resistant to the drug in Japan.
    Nagase H; Moriwaki K; Kamae M; Yanagisawa S; Kamae I
    Value Health; 2009; 12 Suppl 3():S62-5. PubMed ID: 20586984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oseltamivir Treatment for Children with Influenza-Like Illness in China: A Cost-Effectiveness Analysis.
    Shen K; Xiong T; Tan SC; Wu J
    PLoS One; 2016; 11(4):e0153664. PubMed ID: 27082431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-exposure influenza prophylaxis with oseltamivir: cost effectiveness and cost utility in families in the UK.
    Sander B; Hayden FG; Gyldmark M; Garrison LP
    Pharmacoeconomics; 2006; 24(4):373-86. PubMed ID: 16605283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oseltamivir for influenza postexposure prophylaxis: economic evaluation for children aged 1-12 years in the U.S.
    Talbird SE; Brogan AJ; Winiarski AP
    Am J Prev Med; 2009 Nov; 37(5):381-8. PubMed ID: 19840692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.